One tenant. Every border.

How licences and permits work

Cannabis is controlled under the UN Single Convention on Narcotic Drugs of 1961. National authorities license each operator and authorise each international shipment: the exporting country issues an export authorisation that refers to the importing country's import authorisation. Quantities are tracked against national estimates, and every operator keeps a stock book the authority can inspect.

For an ERP this means three hard rules: no order without valid licences on both sides; no shipment beyond the balance of its authorisation; and a stock book that reconciles to the item ledger for any period. 365Phyta enforces all three.

Germany: MedCanG and BfArM

Status in 365Phyta: Available at launch

• Law: since 1 April 2024 medical cannabis is regulated by the Medical Cannabis Act (Medizinal-Cannabisgesetz, MedCanG) instead of the Narcotics Act (BtMG).
• Authority: the Federal Institute for Drugs and Medical Devices (BfArM) applies the MedCanG.
• Operator permit: cultivating, manufacturing, trading, importing, exporting or otherwise placing medical cannabis on the market requires a permit from BfArM under section 4 MedCanG.
• Per-shipment authorisation: each import or export also needs an import or export authorisation from BfArM (sections 12 and 14 MedCanG). The procedure follows the Narcotics Foreign Trade Ordinance (BtMAHV).
• Volumes: Germany imported 201.1 t of medical cannabis in 2025, up from 72.85 t in 2024; Canada supplied about 93 t and Portugal about 55 t (BfArM data via StratCann).

What the German adapter does

It keeps the BfArM permit in the licence register, links every inbound shipment to its import authorisation and blocks receipt beyond the authorised quantity, and produces the stock book and authority reports in the required format. Imported lots then move through QP release and GDP distribution to pharmacies.

Portugal: Decreto-Lei 8/2019 and INFARMED

Status in 365Phyta: Available at launch

• Law: Decreto-Lei n.º 8/2019 of 15 January 2019 sets the framework for medicines, preparations and substances based on the cannabis plant for medicinal purposes.
• Authority: INFARMED authorises cultivation, manufacturing, wholesale trade, import and export, exclusively for medicinal, veterinary and scientific purposes.
• Renewal: authorisations are valid for no more than one year, and holders must request renewal annually or the authorisation lapses. Applications go through INFARMED's Licenciamento+ portal.
• Exports: Portugal is one of Germany's largest suppliers, with about 55 t in 2025.

What the Portuguese adapter does

It keeps each INFARMED authorisation in the licence register with its scope and expiry date, and matches every export authorisation to the destination country's import authorisation before a shipment can be released.

Next markets

Next Canada and Australia. On the roadmap: Denmark, the Netherlands, the Czech Republic, Poland, Thailand, Colombia and North Macedonia. Adding a market is a data update to a country adapter, not a rebuild. If you need a market that is not listed, tell us.

FAQ

Sources

1. BfArM, Bundesopiumstelle: Medizinisches Cannabis, including Erlaubnis and Einfuhr und Ausfuhr.
2. Diário da República, Decreto-Lei n.º 8/2019.
3. INFARMED, Canábis para fins medicinais.
4. StratCann, "Canada continued to supply bulk of German medical cannabis imports in 2025" (BfArM data).
5. UNODC, Single Convention on Narcotic Drugs, 1961.

Last reviewed: September 2026. Rules change; check with the authority before you act. This page is not legal advice.